Laparoscopic Roux-en-Y Gastric Bypass

Authors:

Abstract
Over the past 20 years, the United States and the world at large have seen a staggering increase in the prevalence of obesity. Recent surveys by the Centers for Disease Control and Prevention (Atlanta, Ga) suggest that more than 64% of US adults are overweight and 5% are morbidly obese, defined as having a body mass index (BMI) greater than or equal to 40 kg/m2.1 Obesity is associated with health-affecting comorbidities such as diabetes mellitus, hyperlipidemia, hypertension, and obstructive sleep apnea. These adverse conditions contribute to the increased risk for premature death and disability for persons with BMIs greater than 25.2 Commonly refractory to conservative weight loss treatments, morbid obesity has become a surgical disease. Operations to treat obesity are the most effective interventions for achieving meaningful and sustainable weight loss.3 Mirroring the rise in prevalence of obesity has been the dramatic increase in the number of bariatric procedures performed. In fact, the number of procedures performed yearly in the United States has increased a staggering 644% in the last decade.4 This increase can be attributed to the increased public awareness of the health risk associations of obesity and its staggering societal cost and the greater acceptance of surgery as a legitimate treatment. Equally significant is the adaptation of minimally invasive techniques to the field of bariatric surgery.